Defining criteria for rheumatoid arthritis patient-derived disease activity score that correspond to Disease Activity Score 28 and Clinical Disease Activity Index based disease states and response criteria
- 31 July 2016
- journal article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 55 (11) , 1954-1958
Abstract
Objective. Two versions of a patient-based DAS (PDAS) 1 and 2 (with and without ESR) have been developed and validated in RA. The objective of this study was to define PDAS1- and PDAS2-based criteria for remission, low, moderate and high disease activity and responses to treatment.Keywords
This publication has 13 references indexed in Scilit:
- Treating rheumatoid arthritis to target: recommendations of an international task forceAnnals of the Rheumatic Diseases, 2010
- Fibromyalgic rheumatoid arthritis and disease assessmentRheumatology, 2010
- Evidence for predictive validity of remission on long‐term outcome in rheumatoid arthritis: A systematic reviewArthritis Care & Research, 2009
- American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease‐modifying antirheumatic drugs in rheumatoid arthritisArthritis Care & Research, 2008
- Development and validation of a patient‐based disease activity score in rheumatoid arthritis that can be used in clinical trials and routine practiceArthritis Care & Research, 2008
- Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity scoreArthritis Research & Therapy, 2005
- A simplified disease activity index for rheumatoid arthritis for use in clinical practiceRheumatology, 2003
- Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritisArthritis & Rheumatism, 1995
- Epidemiology of rheumatoid arthritisAPMIS, 1994
- LONG-TERM OUTCOME OF TREATING RHEUMATOID ARTHRITIS: RESULTS AFTER 20 YEARSThe Lancet, 1987